19:32 , Dec 5, 2017 |  BC Innovations  |  Distillery Techniques

Assays and screens

TECHNOLOGY: Cell-free assays; diagnostic assays An assay for detecting GPC1 mRNA in serum extracellular vesicles could help diagnose PDAC. The assay involves adding patient serum samples to a slide coated with cationic liposomes loaded with...
21:00 , Jun 22, 2017 |  BC Innovations  |  Targets & Mechanisms

Exosomes deliver

Codiak BioSciences Inc. founder Raghu Kalluri has published the first animal data demonstrating exosomes can be used as drug delivery vehicles to treat cancer -- not just diagnose it. The findings also mark the unveiling...
07:00 , Oct 13, 2016 |  BC Innovations  |  Strategy

Exosomes in the zone

Mark Zipkin, Staff Writer  Having had a slow on-ramp to recognition as more than cellular garbage bags, exosomes are gaining status as a potentially transformational technology, with utility in both diagnostics and therapeutics. But the...
01:47 , Jan 27, 2016 |  BC Extra  |  Financial News

Exosome play Codiak closes $61M B round

Exosome-based diagnostics and therapeutics play Codiak BioSciences Inc. (Cambridge, Mass.) said it closed a series B round with $61 million. Flagship Ventures and Arch Venture Partners co-led both the new round and Codiak's $31 million...
08:00 , Nov 23, 2015 |  BioCentury  |  Emerging Company Profile

Exosome exploitation

Fresh off his tenure as head of R&D for Biogen Inc. , Douglas Williams opted to co-found Codiak BioSciences Inc. to exploit exosomes to diagnose cancer without the need for sequencing, and to extend the...
02:02 , Nov 18, 2015 |  BC Extra  |  Financial News

Newco Codiak launched

Codiak BioSciences Inc. (Cambridge, Mass.) made its debut Tuesday with the first tranche of a planned $80 million combined series A and B financing led by Flagship Ventures and Arch Venture Partners. Douglas Williams, former...
07:00 , Jul 30, 2015 |  BC Innovations  |  Distillery Techniques

Techniques: Glypican 1 (GPC1)-containing exosomes in serum as diagnostic marker of breast and pancreatic cancers

Biomarkers GPC1 Glypican 1 University of Texas MD Anderson Cancer Center...